What is the level of liabilities of Shandong Weigao Group Medical Polymer Co this year?
Shandong Weigao Group Medical Polymer Co has a debt balance of 11.22 B CNY this year.
In 2024, Shandong Weigao Group Medical Polymer Co's total liabilities amounted to 11.22 B CNY, a -3.56% difference from the 11.64 B CNY total liabilities in the previous year.
Shandong Weigao Group Medical Polymer Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Shandong Weigao Group Medical Polymer Co's financial stability, operational efficiency, and long-term viability.
By comparing Shandong Weigao Group Medical Polymer Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Shandong Weigao Group Medical Polymer Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Shifts in Shandong Weigao Group Medical Polymer Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Shandong Weigao Group Medical Polymer Co has a debt balance of 11.22 B CNY this year.
The liabilities of Shandong Weigao Group Medical Polymer Co have increased by -3.56% dropped compared to the previous year.
High liabilities can pose a risk for investors of Shandong Weigao Group Medical Polymer Co, as they can weaken the company's financial position and impair its ability to meet its obligations.
Low liabilities mean that Shandong Weigao Group Medical Polymer Co has a strong financial position and is able to meet its obligations without overburdening its finances.
An increase in liabilities of Shandong Weigao Group Medical Polymer Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
A decrease in the liabilities of Shandong Weigao Group Medical Polymer Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
Some factors that can influence the liabilities of Shandong Weigao Group Medical Polymer Co include investments, acquisitions, operating costs, and sales development.
The liabilities of Shandong Weigao Group Medical Polymer Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
To change its liabilities, Shandong Weigao Group Medical Polymer Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
Over the past 12 months, Shandong Weigao Group Medical Polymer Co paid a dividend of 0.25 CNY . This corresponds to a dividend yield of about 6.24 %. For the coming 12 months, Shandong Weigao Group Medical Polymer Co is expected to pay a dividend of 0.27 CNY.
The current dividend yield of Shandong Weigao Group Medical Polymer Co is 6.24 %.
Shandong Weigao Group Medical Polymer Co pays a quarterly dividend. This is distributed in the months of November, July, July, November.
Shandong Weigao Group Medical Polymer Co paid dividends every year for the past 23 years.
For the upcoming 12 months, dividends amounting to 0.27 CNY are expected. This corresponds to a dividend yield of 6.79 %.
Shandong Weigao Group Medical Polymer Co is assigned to the 'Health' sector.
To receive the latest dividend of Shandong Weigao Group Medical Polymer Co from 11/22/2024 amounting to 0.092 CNY, you needed to have the stock in your portfolio before the ex-date on 10/18/2024.
The last dividend was paid out on 11/22/2024.
In the year 2023, Shandong Weigao Group Medical Polymer Co distributed 0.172 CNY as dividends.
The dividends of Shandong Weigao Group Medical Polymer Co are distributed in CNY.
Our stock analysis for Shandong Weigao Group Medical Polymer Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shandong Weigao Group Medical Polymer Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.